Back to top

The Zacks Analyst Blog Highlights: Dr. Reddy's Laboratories, Infosys, ICICI Bank and HDFC Bank

Read MoreHide Full Article

For Immediate Release

Chicago, IL – August 10, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Dr. Reddy's Laboratories Ltd. (RDY - Free Report) , Infosys Ltd. (INFY - Free Report) , ICICI Bank Ltd. (IBN - Free Report) and HDFC Bank Ltd. (HDB - Free Report) .

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Thursday’s Analyst Blog:

Indian Stocks in Focus as IMF Appreciates Its Economic Growth

The government of India recently received a shot in the arm with the International Momentary Fund (IMF) applauding the country’s economic growth. The IMF stated “Indian economy is a like an elephant that is starting to run as the country remains one of the fastest growing economies in the world”.

IMF Raises India’s GDP Projections

According to the IMF, Indian economy is gaining momentum as a result of several policy reforms taken by Prime Minister Narendra Modi’s administration in the last four years. Consequently, the IMF has raised the country’s GDP growth rate to 7.3% for fiscal 2018-2019 (India’s fiscal year starts in April and ends on March of the next year) from 6.7% in fiscal 2017-2018.

Further, the agency projected 7.5% GDP growth rate for fiscal 2019-2020. Moreover, the IMF expects India's GDP growth to rise to 7.75% over the medium term.

Economic Reforms Pay-Off

On Nov 8, 2016, Modi announced that the government of India has decided to demonetize its high-value currency notes. This was one of the boldest steps taken by any Indian Prime Minister ever in a bid to clean up the financial sector from notorious parallel economy, the main hindrance to India’s economic growth, security and prosperity.

On Aug 8, 2016, Indian parliament adopted a nationwide goods-and-services tax, or GST. The step blended a variety of state and central levies into a national sales tax, resulting in a solo customs union for India’s 1.3 billion people. The move has made business transactions seamless and lowered cost of production of goods. In addition, the government of India plans to boost infrastructure and open up industries such as railways and defense to foreign investment.

Momentum Likely to Continue

On November 2017, India, for the first time secured a place in the top 100 of the World Bank’s Ease of Doing Business (EDB) global rankings. According to the World Bank’s Global Economic Prospects in January 2018, Indian economy is likely to grow at 7.3% in 2018.

In February 2018, Moody’s Investors Service projected India’s GDP growth rate at 7.6% for 2018 and 7.5% for 2019. In November 2017, the rating agency upgraded India’s sovereign bond rating for the first time in nearly 14 years.

Moody’s was optimistic about structural reforms undertaken by the Modi administration is likely to boost growth and reduce the debt burden. Moody’s lifted India’s rating to Baa2 from Baa3 and changed its rating outlook to stable from positive as “risks to its credit profile were broadly balanced”.

Indian Stocks in Focus

India is likely to become the fifth largest economy in the world in 2018. The country has a massive population of which 70% are below the age of 35 and are extremely tech savvy. Improving current account deficit, a recovery in private investment, introduction of the GST, and a stable monetary policy are major positives for the economy.

At this stage, Indian stocks which are listed in the U.S. stock exchanges are likely to benefit most. Dr. Reddy's Laboratories Ltd., Infosys Ltd., ICICI Bank Ltd. and HDFC Bank Ltd. are likely to gain. Dr. Reddy's Laboratories, Infosys and ICICI Bank carry a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 (Strong Buy) Rank stocks here.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Follow us on Twitter: https://twitter.com/zacksresearch

Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

https://www.zacks.com/

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.



More from Zacks Press Releases

You May Like